Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Alavi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transfusion|September 1, 1982
Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsisM B Dahlke, M Keashen, J B Alavi, et al.
Nuclear Medicine Communications|July 1, 1987
Sequential computerized tomography and positron emission tomography studies in a patient with malignant gliomaJ B Alavi, A Alavi, H I Goldberg, et al.
Cancer|September 15, 1988
Positron emission tomography in patients with glioma. A predictor of prognosisJ B Alavi, A Alavi, J Chawluk, et al.
American Journal of Clinical Oncology|February 1, 1989
Phase II trial of spirogermanium and vindesine in malignant gliomaJ B Alavi, D Schoenfeld, R T Skeel, et al.
Transfusion|September 1, 1980
Response to granulocyte transfusions in the alloimmunized patientM B Dahlke, M A Keashen, J B Alavi, et al.
Investigational New Drugs|November 3, 2006
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiformeTom Mikkelsen, Richard Lush, Stuart A Grossman, et al.
Neuro-Oncology|August 2, 2005
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaSteven Brem, Stuart A Grossman, Kathryn A Carson, et al.
Neuro-Oncology|February 11, 2005
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomasStuart A Grossman, Jane B Alavi, Jeffrey G Supko, et al.
Journal of Neuro-Oncology|May 7, 2011
Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomasMichelle A Rudek, Pamela New, Tom Mikkelsen, et al.
Human Gene Therapy|February 15, 2001
Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trialS L Eck, J B Alavi, K Judy, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transfusion|September 1, 1982
Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsisM B Dahlke, M Keashen, J B Alavi, et al.
Nuclear Medicine Communications|July 1, 1987
Sequential computerized tomography and positron emission tomography studies in a patient with malignant gliomaJ B Alavi, A Alavi, H I Goldberg, et al.
Cancer|September 15, 1988
Positron emission tomography in patients with glioma. A predictor of prognosisJ B Alavi, A Alavi, J Chawluk, et al.
American Journal of Clinical Oncology|February 1, 1989
Phase II trial of spirogermanium and vindesine in malignant gliomaJ B Alavi, D Schoenfeld, R T Skeel, et al.
Transfusion|September 1, 1980
Response to granulocyte transfusions in the alloimmunized patientM B Dahlke, M A Keashen, J B Alavi, et al.
Investigational New Drugs|November 3, 2006
Phase II clinical and pharmacologic study of radiation therapy and carboxyamido-triazole (CAI) in adults with newly diagnosed glioblastoma multiformeTom Mikkelsen, Richard Lush, Stuart A Grossman, et al.
Neuro-Oncology|August 2, 2005
Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastomaSteven Brem, Stuart A Grossman, Kathryn A Carson, et al.
Neuro-Oncology|February 11, 2005
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomasStuart A Grossman, Jane B Alavi, Jeffrey G Supko, et al.
Journal of Neuro-Oncology|May 7, 2011
Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomasMichelle A Rudek, Pamela New, Tom Mikkelsen, et al.
Human Gene Therapy|February 15, 2001
Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trialS L Eck, J B Alavi, K Judy, et al.
Pageof 4